Skip to main content

Century Therapeutics, Inc.

IPSC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001850119

In the last 90 days, Century Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 100 institutions reported holding it in 13F filings for Q2 2026, worth $387.0M in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Century Therapeutics, Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023All holders in Q3 2023

13F holders of IPSC: Q3 2023 compared with Q4 2023
MeasureQ3 2023Q4 2023Change
Holders5563+8
Shares18.1M17.7M−385.4K (−2.1%)
Value$36.1M$58.7M+$22.6M (+62.5%)

New holders (15)

Institutions that held Century Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to IPSC in Q4 2023
InstitutionSharesValue% of portfolio
Tang Capital Management LLC1,066,440$3.54M0.33%
Millennium Management LLC138,960$461.3K0.00%
Susquehanna International Group, LLP22,629$75.1K0.00%
Jane Street Group, LLC17,687$58.7K0.00%
HRT Financial LP17,528$58.0K0.00%
XTX Topco Ltd14,177$47.1K0.01%
Virtu Financial LLC14,018$47.0K0.00%
Abel Hall, LLC10,071$33.4K0.03%
Neuberger Berman Group LLC10,028$33.3K0.00%
Founders Financial Securities LLC10,000$33.2K0.00%
GAMMA Investing LLC176$7530.00%
Nisa Investment Advisors, LLC111$3690.00%
Qube Research & Technologies Ltd8$270.00%
Simplex Trading, LLC294$00.00%
Covestor Ltd3$00.00%

Sold out (7)

Institutions that held Century Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of IPSC in Q4 2023
InstitutionShares, Q3 2023Value, Q3 2023
Deep Track Capital, LP543,008$1.09M
Ameriprise Financial Inc18,400$36.8K
Gladius Capital Management LP9,810$19.6K
Public Employees Retirement System of Ohio8,735$17.0K
China Universal Asset Management Co., Ltd.1,528$3.06K
Daiwa Securities Group Inc.159$0
CWM, LLC45$0